Drug recall · September 19, 2018
Pramipexole dihydrochloride extended release tablets recall
Why: Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11
- Lots / codes
Lot #: 29906202, Exp 12/18; 29993102, Exp 2/19; 30366102, 30373103, Exp 4/19; 31940601, Exp 3/20.
- Quantity
- 16,207 (bottles of 30 tablets)
- Company
- Par Pharmaceutical, Inc., Chestnut Ridge, NY
- Distribution
- United States nationwide
- Initiated
- September 6, 2018 · Voluntary: Firm initiated
- Classified
- September 10, 2018
- Reported
- September 19, 2018
- Ended
- December 6, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pramipexole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.